Literature DB >> 8825036

Use of thapsigargin to study Ca2+ homeostasis in cardiac cells.

T B Rogers1, G Inesi, R Wade, W J Lederer.   

Abstract

Several reports have documented that thapsigargin is a potent inhibitor of the SR Ca2+ ATPase isolated from cardiac or skeletal muscle. We have characterized the specificity of this agent in intact rat cardiac myocytes using cells maintained in the whole cell voltage clamp configuration. We have shown that thapsigargin decreases the magnitude of the Ca2+ transient and the twitch by about 80% while it slows the decay rate for these responses. These changes were not accompanied by any alterations in sarcolemmal currents or in the trigger Ca2+ generated by the inward calcium current. Taken together these results reveal that the action of thapsigargin is restricted to the SR Ca2+ ATPase in intact cardiac myocytes. Furthermore, it is demonstrated unambiguously that SR intracellular Ca2+ stores are an absolute requirement for the development of contractile tension in rat heart myocytes. It is shown that thapsigargin is a valuable probe to examine the importance of SR pools of Ca2+ and the role of the Ca2+ ATPase in intact myocytes as well as in genetically altered heart cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8825036     DOI: 10.1007/bf01788366

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  59 in total

1.  Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII.

Authors:  Corina E Antal; Julia A Callender; Alexandr P Kornev; Susan S Taylor; Alexandra C Newton
Journal:  Cell Rep       Date:  2015-08-13       Impact factor: 9.423

2.  A method to measure myocardial calcium handling in adult Drosophila.

Authors:  Na Lin; Nima Badie; Lin Yu; Dennis Abraham; Heping Cheng; Nenad Bursac; Howard A Rockman; Matthew J Wolf
Journal:  Circ Res       Date:  2011-04-14       Impact factor: 17.367

3.  Ryanodine and IP3 receptor-mediated calcium signaling play a pivotal role in neurological infrared laser modulation.

Authors:  Gleb P Tolstykh; Cory A Olsovsky; Bennett L Ibey; Hope T Beier
Journal:  Neurophotonics       Date:  2017-04-05       Impact factor: 3.593

4.  MicroRNA-23a Curbs Necrosis during Early T Cell Activation by Enforcing Intracellular Reactive Oxygen Species Equilibrium.

Authors:  Baojun Zhang; Si-Qi Liu; Chaoran Li; Erik Lykken; Shan Jiang; Elizabeth Wong; Zhihua Gong; Zhongfen Tao; Bo Zhu; Ying Wan; Qi-Jing Li
Journal:  Immunity       Date:  2016-02-23       Impact factor: 31.745

5.  Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

Authors:  Benjamin T Kopp; James Fitch; Lisa Jaramillo; Chandra L Shrestha; Frank Robledo-Avila; Shuzhong Zhang; Sabrina Palacios; Fred Woodley; Don Hayes; Santiago Partida-Sanchez; Octavio Ramilo; Peter White; Asuncion Mejias
Journal:  J Cyst Fibros       Date:  2019-08-29       Impact factor: 5.482

6.  Cholesterol loss during glutamate-mediated excitotoxicity.

Authors:  Alejandro O Sodero; Joris Vriens; Debapriya Ghosh; David Stegner; Anna Brachet; Marta Pallotto; Marco Sassoè-Pognetto; Jos F Brouwers; J Bernd Helms; Bernhard Nieswandt; Thomas Voets; Carlos G Dotti
Journal:  EMBO J       Date:  2012-02-17       Impact factor: 11.598

7.  The natural sesquiterpene lactones arglabin, grosheimin, agracin, parthenolide, and estafiatin inhibit T cell receptor (TCR) activation.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Pete T Mitchell; Аnarkul S Kishkentaeva; Zhanar R Shaimerdenova; Gayane A Atazhanova; Sergazy M Adekenov; Mark T Quinn
Journal:  Phytochemistry       Date:  2017-12-22       Impact factor: 4.072

8.  Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategy.

Authors:  Stephen D Dertinger; Andrew R Kraynak; Ryan P Wheeldon; Derek T Bernacki; Steven M Bryce; Nikki Hall; Jeffrey C Bemis; Sheila M Galloway; Patricia A Escobar; George E Johnson
Journal:  Environ Mol Mutagen       Date:  2019-02-27       Impact factor: 3.216

9.  Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Dennisse Gonzalez-Romero; Kristi Green; Giulio Taglialatela; Claudio Soto
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

10.  The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation.

Authors:  Mariclair A Reeves; Frederick P Bellinger; Marla J Berry
Journal:  Antioxid Redox Signal       Date:  2010-04-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.